88IV - Public company info - Jacobio Pharmaceuticals Group Co. Ltd.

Input the stock code or the company name

Jacobio Pharmaceuticals Group Co. Ltd. - B, 01167.HK - Cash Flow	2021-12	2020-12	2019-12	2018-12
Net Cash Flow from Operating Activities	-162,949	76,789	-115,620	-80,080
Net Cash Flow from Return on Investments & Servicing of Finance	15,493	179	5,153	-16,603
Interest Received	16,006	2,036	5,332	446
Interest Paid	-513	-1,857	-179	0
Dividend Received	0	0	0	0
Dividend Paid	0	0	0	-17,049
Others	0	0	0	0
Taxes (Paid) / Refunded	0	0	0	0
Net Cash Flow from Investing Activities	161,118	-215,564	-3,010	14,325
Additions to Fixed Assets	-10,106	-10,138	-3,342	-11,080
Disposal of Fixed Assets	10	32	23	0
Increase in Investments	-16,144	-194,000	-26,000	-150,610
Decrease in Investments	0	194,686	26,000	179,504
Net Cash Flow with Related Parties	0	11,681	-10,200	-2,751
Others	187,358	-217,825	10,509	-738
Net Cash Flow before Financing Activities	13,662	-138,596	-113,477	-82,358
Net Cash Flow from Financing Activities	109,570	1,277,238	1,108	373,876
New Loans	0	0	0	0
Loans Repayment	-11,369	-8,457	-692	0
Fixed Income/Debt Instruments	0	182,497	0	376,627
Repayment of Fixed Income/Debt Instruments	0	0	0	0
Equity Financing	120,939	1,103,517	0	0
Net Cash Flow with Related Parties	0	11,681	-10,200	-2,751
Others	0	-12,000	12,000	0
Increase(Decrease) in Cash & Cash Equivalents	123,232	1,138,642	-112,369	291,518
Cash & Cash Equivalents at Beginning of Year	1,430,416	314,338	420,833	126,865
Net Cash Flow due to Change in Exchange Rate/Others	-26,444	-22,564	5,874	2,450
Cash & Cash Equivalents at End of Year	1,527,204	1,430,416	314,338	420,833
Currency	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Jacobio Pharmaceuticals Group Co. Ltd. - B , 01167.HK